The key players of this market include Allergan Plc., Nestle S.A. (Galderma S.A.), Johnson & Johnson, Mayne Pharma Group Limited, Mylan N.V., Pfizer Inc., GlaxoSmithKline Plc (Stiefel Laboratories, Inc.), Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and Valeant Pharmaceuticals International, Inc.
Chapter: 1: COMPANY PROFILES
1.1. Allergan Plc
1.1.1. Company overview
1.1.2. Company snapshot
1.1.3. Operating business segments
1.1.4. Product portfolio
1.1.5. Business performance
1.1.6. Key strategic moves and developments
1.2. Nestle S.A. (Galderma S.A.)
1.2.1. Company overview
1.2.2. Company snapshot
1.2.3. Operating business segments
1.2.4. Product portfolio
1.2.5. Business performance
1.2.6. Key strategic moves and developments
1.3. Johnson & Johnson
1.3.1. Company overview
1.3.2. Company snapshot
1.3.3. Operating business segments
1.3.4. Product portfolio
1.3.5. Business performance
1.4. Mayne Pharma Group Limited
1.4.1. Company overview
1.4.2. Company snapshot
1.4.3. Operating business segments
1.4.4. Product portfolio
1.4.5. Business performance
1.4.6. Key strategic moves and developments
1.5. Mylan N.V.
1.5.1. Company overview
1.5.2. Company snapshot
1.5.3. Operating business segments
1.5.4. Product portfolio
1.5.5. Business performance
1.6. Pfizer Inc.
1.6.1. Company overview
1.6.2. Company snapshot
1.6.3. Operating business segments
1.6.4. Product portfolio
1.6.5. Business performance
1.6.6.
1.7. GlaxoSmithKline Plc (Stiefel Laboratories, Inc.)
1.7.1. Company overview
1.7.2. Company snapshot
1.7.3. Operating business segments
1.7.4. Product portfolio
1.7.5. Business performance
1.8. Sun Pharmaceutical Industries Limited
1.8.1. Company overview
1.8.2. Company snapshot
1.8.3. Operating business segments
1.8.4. Product portfolio
1.8.5. Business performance
1.8.6. Key strategic moves and developments
1.9. Teva Pharmaceutical Industries Ltd.
1.9.1. Company overview
1.9.2. Company snapshot
1.9.3. Operating business segments
1.9.4. Product portfolio
1.9.5. Business performance
1.9.6. Key strategic moves and developments
1.1. Valeant Pharmaceuticals International, Inc.
1.10.1. Company overview
1.10.2. Company snapshot
1.10.3. Operating business segments
1.10.4. Product portfolio
1.10.5. Business performance
1.10.6. Key strategic moves and developments
TABLE 1. ALLERGAN: COMPANY SNAPSHOT
TABLE 2. ALLERGEN: OPERATING SEGMENTS
TABLE 3. ALLERGAN: PRODUCT PORTFOLIO
TABLE 4. NESTLÉ: COMPANY SNAPSHOT
TABLE 5. NESTLÉ: OPERATING SEGMENTS
TABLE 6. NESTLÉ: PRODUCT PORTFOLIO
TABLE 7. J&J: COMPANY SNAPSHOT
TABLE 8. J&J: OPERATING SEGMENTS
TABLE 9. J&J: PRODUCT PORTFOLIO
TABLE 10. MAYNE PHARMA: COMPANY SNAPSHOT
TABLE 11. MAYNE PHARMA: OPERATING SEGMENTS
TABLE 12. MAYNE PHARMA: PRODUCT PORTFOLIO
TABLE 13. MYLAN: COMPANY SNAPSHOT
TABLE 14. MYLAN: OPERATING SEGMENT
TABLE 15. MYLAN: PRODUCT PORTFOLIO
TABLE 16. PFIZER: COMPANY SNAPSHOT
TABLE 17. PFIZER: OPERATING SEGMENTS
TABLE 18. PFIZER: PRODUCT PORTFOLIO
TABLE 19. GSK: COMPANY SNAPSHOT
TABLE 20. GSK: OPERATING SEGMENTS
TABLE 21. GSK: PRODUCT PORTFOLIO
TABLE 22. SUN PHARMA: COMPANY SNAPSHOT
TABLE 23. SUN PHARMA: OPERATING SEGMENTS
TABLE 24. SUN PHARMA: PRODUCT PORTFOLIO
TABLE 25. TEVA: COMPANY SNAPSHOT
TABLE 26. TEVA: OPEARTING SEGMENT
TABLE 27. TEVA: PRODUCT PORTFOLIO
TABLE 28. VALEANT: COMPANY SNAPSHOT
TABLE 29. VALEANT.: OPERATING SEGMENTS
TABLE 30. VALEANT: PRODUCT PORTFOLIO
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers